Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a “strategic partnership” with OpenAI to accelerate the development of new medications.Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a “strategic partnership” with OpenAI to accelerate the development of new medications.Machine learning & AI[#item_full_content]